VYNE THERAPEUTICS INC's ticker is VYNE and the CUSIP is 92941V209. A total of 46 filers reported holding VYNE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $3,620 | -27.6% | 24,131 | 0.0% | 0.00% | – |
Q3 2022 | $5,000 | -50.0% | 24,131 | -4.5% | 0.00% | – |
Q2 2022 | $10,000 | -37.5% | 25,264 | 0.0% | 0.00% | -100.0% |
Q1 2022 | $16,000 | -38.5% | 25,264 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $26,000 | -25.7% | 25,264 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $35,000 | -60.7% | 25,264 | 0.0% | 0.00% | -75.0% |
Q2 2021 | $89,000 | -48.6% | 25,264 | 0.0% | 0.00% | -42.9% |
Q1 2021 | $173,000 | – | 25,264 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 400,000 | $2,738,000 | 6.10% |
DSC Advisors, L.P. | 1,038,145 | $7,106,000 | 4.40% |
CM Management, LLC | 143,750 | $984,000 | 0.73% |
Perceptive Advisors | 6,773,954 | $46,368,000 | 0.59% |
DELTEC ASSET MANAGEMENT LLC | 441,491 | $3,022,000 | 0.45% |
Perennial Investment Advisors, LLC | 35,000 | $240,000 | 0.10% |
Tekla Capital Management LLC | 135,395 | $927,000 | 0.03% |
NEXPOINT ASSET MANAGEMENT, L.P. | 10,051 | $69,000 | 0.02% |
AXA S.A. | 882,124 | $6,038,000 | 0.02% |
STALEY CAPITAL ADVISERS INC | 25,000 | $171,000 | 0.01% |